The Time for Cancer Vaccines Is Now

This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.

Corresponding Author: Kiranjit K. Dhillon, PhD, Cancer Vaccine Institute, University of Washington, 850 Republican St, Box 358050, Seattle, WA 98109 (kkd@uw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.